Effects of repeated green tea catechin administration on human cytochrome P450 activity

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 12, 2006, Pages 2473-2476

  Chow, H H Sherry ^a   Hakim, Iman A ^a   Vining, Donna R ^a   Crowell, James A ^b   Cordova, Catherine A ^a   Chew, Wade M ^a   Xu, Min Jian ^a   Hsu, Chiu Hsieh ^a   Ranger Moore, James ^a   Alberts, David S ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 BUTYL 4 CHLORO 1 [[2' (1H TETRAZOL 5 YL) 4 BIPHENYLYL]METHYL] 5 IMIDAZOLECARBOXYLIC ACID; BUSPIRONE; CAFFEINE; CATECHIN; CYTOCHROME P450; CYTOCHROME P450 1A2; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 3A4; DEXTROMETHORPHAN; DEXTRORPHAN; EPIGALLOCATECHIN GALLATE; GREEN TEA EXTRACT; LOSARTAN; PARAXANTHINE; POLYPHENON E; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG EFFECT; DRUG METABOLISM; DRUG URINE LEVEL; DYSPEPSIA; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; FLATULENCE; FLUSHING; HUMAN; LOW DRUG DOSE; MALE; NAUSEA; NORMAL HUMAN; PRIORITY JOURNAL; SIDE EFFECT; VOMITING;

ADMINISTRATION, ORAL; ADULT; AGED; CAMELLIA SINENSIS; CATECHIN; CYTOCHROME P-450 CYP2D6; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; HUMANS; MALE; MIDDLE AGED; TEA;

EID: 33845971869     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-06-0365     Document Type: Article

References (25)

1. Gloro R, Hourmand-Ollivier I, Mosquet B, et al. Fulminant hepatitis during self-medication with hydroalcoholic extract of green tea. Eur J Gastroenterol Hepatol 2005;17:1135-7.
2. Bonkovsky H. Hepatotoxicity associated with supplements containing Chinese green tea (Camellia sinesis). Ann Intern Med 2006;144:68-9.
3. Maliakal PP, Coville PF, Wanwimolruk S. Tea consumption modulates hepatic drug metabolizing enzymes in Wistar rats. J Pharm Pharmacol 2001;53:569-77.
4. Bu-Abbas A, Clifford MN, Walker R, Ioannides C. Selective induction of rat hepatic CYP1 and CYP4 proteins and of peroxisomal proliferation by green tea. Carcinogenesis 1994;15:2575-9.
5. Sohn OS, Surace A, Fiala ES, et al. Effects of green and black tea on hepatic xenobiotic metabolizing systems in the male F344 rat. Xenobiotica 1994;24:119-27.
6. Danielson P. The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans. Curr Drug Metab 2002;3:561-7.
7. Dresser G, Bailey D. A basic conceptual and practical overview of interactions with highly prescribed drugs. Can J Clin Pharmacol 2002;9:191-8.
8. Christensen M, Andersson K, Dalen P, et al. The Karolinska cocktail for phenotyping of five human cytochrome P450 enzymes. Clin Pharmacol Ther 2003;73:517-28.
9. Park YH, Kullberg MP, Hinsvark ON. Quantitative determination of dextromethorphan and three metabolites in urine by reverse-phase high-performance liquid chromatography. J Pharm Sci 1984;73:24-9.
10. Lam YWF, Rodriguez SY. High-performance liquid chromatography determination of dextromethorphan and dextrorphan for oxidation phenotyping by fluorescence and ultraviolet detection. Ther Drug Monit 1993;15:300-4.
11. Ritter MA, Furtek CI, Lo MW. An improved method for the simultaneous determination of losartan and its major metabolite, EXP3174, in human plasma and urine by high-performance liquid chromatography with fluorescence detection. J Pharm Biomed Anal 1987;15:1021-9.
12. Chew W, Xu MJ, Cordova C, Chow HHS. Quantification of a cytochrome P450 3A4 substrate, buspirone, in human plasma by liquid chromatography-tandem mass spectrometry. J Chromatogr B. In press.
13. Lilja J, Kivisto K, Backman J, Lamberg T, Neuvonen P. Grapefruit juice substantially increases plasma concentrations of buspirone. Clin Pharmacol Ther 1998;64:655-60.
14. Wang Z, Gorski JC, Hamman MA, Huang SM, Lesko LJ, Hall SD. The effect of St. John's wort (Hypericum perforatum) on human cytochrome P450 activity. Clin Pharmacol Ther 2001;70:317-26.
15. Kashuba AD, Nafziger AN, Kearns GL, et al. Effect of fluvoxamine therapy on the activities of CYP1A2, CYP2D6, and CYP3A as determined by phenotyping. Clin Pharmacol Ther 1998;64:257-68.
16. Streetman DS, Bleakley JF, Kim JS, et al. Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail." Clin Pharmacol Ther 2000;68:375-83.
17. Donovan JL, Chavin KD, Devane CL, et al. Green tea (Camellia sinesis) extract does not alter cytochrome p450 3A4 or 2D6 activity in healthy volunteers. Drug Metab Dispos 2004;32:906-8.
18. Bjornsson T, Callaghan J, Einolf H, et al. The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective. Drug Metab Dispos 2003;31:815-32.
19. Graham HN. Green tea composition, consumption, and polyphenol chemistry. Prev Med 1992;21:334-50.
20. Chow HHS, Hakim IA, Vining DR, et al. Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals. Clin Cancer Res 2005;11:4627-33.
21. Ayalogu E, Snelling J, Lewis D, Talwar S, Clifford M, Ioannides C. Induction of hepatic CYP1A2 by the oral administration of caffeine to rats: lack of association with the Ah locus. Biochim Biophys Acta 1995;1272:89-94.
22. Goasduff T, Dreano Y, Guillois B, Mendez J, Berthou F. Induction of liver and kidney CYP1A1/1A2 by caffeine in rat. Biochem Pharmacol 1996;52:1915-9.
23. Dorne JLCM. Impact of inter-individual differences in drug metabolism and pharmacokinetics on safety evaluation. Fundam Clin Pharmacol 2004;18:609-20.
24. Durnas C, Loi CM, Cusack BJ. Hepatic drug metabolism and aging. Clin Pharmacokinet 1990;19:359-89.
25. Chow HHS, Cai Y, Hakim IA, et al. Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clin Cancer Res 2003;9:3312-9.